Abstract 18022: Comparison of Moderate-Intensity Statin-Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Atherosclerotic Cardiovascular Disease
Introduction: Residual cardiovascular risk remains substantial among patients with established atherosclerotic cardiovascular disease (ASCVD), highlighting the importance of optimizing lipid-lowering therapy. While both high-intensity statin monotherapy and moderate-intensity statin plus ezetimibe combination therap...